Current Medicinal Chemistry-Cardiovascular & Hematological Agents

Titel Veröffentlichungsdatum Sprache Zitate
Molecular Predictors of Drug-induced Prolongation of the QT Interval2005/04/01English9
Potent Non-Peptide Thrombin Receptor Antagonists2003/03/01English8
Progress in the Field of GPIIb/IIIa Antagonists2004/04/01English8
Emerging Technologies in Biocompatible Surface Modifying Additives: Quest for Physiologic Cardiopulmonary Bypass2004/10/01English8
Novel Human Plasma Proteins, IHRP (Acute Phase Protein) and PHBP (Serine Protease), Which Bind to Glycosaminoglycans2004/07/01English8
Protease-Activated Receptor-2 Antagonists and Agonists2003/03/01English7
Estrogens Acting as Cardiovascular Agents: Direct Vascular Actions2004/01/01English7
Recent Developments in Cardiovascular Drug Therapy: Treatment of Atrial Arrhythmias with New Class III Drugs and beyond2004/01/01English7
Stent-Based Delivered Anti-Proliferative Drugs in the Prevention of Coronary Stent Restenosis2005/07/01English6
Blockers of the ATP-Sensitive Potassium Channel SUR2A / Kir6.2: A New Approach to Prevent Sudden Cardiac Death2003/10/01English6
Modulators of Ion Channels Activated by Hypotonic Swelling in Cardiomyocytes: New Perspectives for Pharmacological Treatment of Life-Threatening Arrhythmias2005/10/01English5
Ethiopathogenesis, Diagnosis and Prevention of Vascular Calcification in End Stage Renal Disease2005/04/01English5
Non-Peptidic Small-Molecule Antagonists of the Human Platelet Thrombin Receptor PAR-12003/03/01English5
1-Azaadamantanes: Pharmacological Applications and Synthetic Approaches2003/06/01English5
Design of a Genetically Modified Soybean Protein Preventing Hypertension Based on an Anti-Hypertensive Peptide Derived from Ovalbumin2003/06/01English4
Antiarrhythmic Therapy on Prevention of Postoperative Atrial Fibrillation in Patients After Heart Surgery2004/01/01English4
Strategic Leukofiltration in Cardiac Surgery2005/10/01English3
Drug Targeting of Estrogen Receptor Signaling in the Cardiovascular System: Preclinical and Clinical Studies2004/04/01English2
Pharmacogenetics in Cardiovascular Antithrombotic Therapy2005/10/01English2
Homocysteine-Lowering Treatment in Coronary Heart Disease2005/10/01English2
Anemia in Chronic Heart Failure - Clinical and Prognostic Significance2005/10/01English2
Recent Development of Peptides from Glycoproteins IIb (αIIβ) and IIIa (β3) that Inhibit Platelet Fibrinogen Binding2005/04/01English2
Protein C Inhibitor as an Anti-Disseminated Intravascular Coagulation Agent - Mechanism and Modification2004/01/01English1
Development of Peptide Inhibitors to Block Type I and Type III Collagen-platelet Interaction2003/06/01English1
Vascular Effects of Antiarrhythmic Drugs and the Roles of K+ Channels2004/04/01English1
Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Mechanical Intervention for Acute Myocardial Infarction2005/07/01English1
Bone Marrow Reconstitution as a Relevant Model of Genetically Programmed Leukemia2003/06/01English1
Influence of Chronic Kidney Disease Development and Renin-angiotensin System Inhibition on Cardiovascular Prognosis2005/01/01English1
Novel Antithrombotic Agents: Indirect Synthetic Inhibitors of Factor Xa and Direct Thrombin Inhibitors. Evidences from Clinical Studies2004/10/01English
Author Index to Volume 22005/01/01English